Abstract:Background AMP-activated protein kinase (AMPK) is an evolutionarily conserved regulator of energy metabolism. AMPK is sensitive to acute perturbations to cellular energy status and leverages fundamental bioenergetic pathways to maintain cellular homeostasis. AMPK is a heterotrimer comprised of αβγ-subunits that in humans are encoded by seven individual genes (isoforms α1, α2, β1, β2, γ1, γ2 and γ3), permitting formation of at least 12 different complexes with personalised biochemical fingerprints and tissue expression patterns. While the canonical activation mechanisms of AMPK are well-defined, delineation of subtle, as well as substantial, differences in the regulation of heterogenous AMPK complexes remain poorly defined. Scope of review Here, taking advantage of multidisciplinary findings, we dissect the many aspects of isoform-specific AMPK function and links to health and disease. These include, but are not limited to, allosteric activation by adenine nucleotides and small molecules, co-translational myristoylation and post-translational modifications (particularly phosphorylation), governance of subcellular localisation, and control of transcriptional networks. Finally, we delve into current debate over whether AMPK can form novel protein complexes (e.g., dimers lacking the α-subunit), altogether highlighting opportunities for future and impactful research. Major conclusions Baseline activity of α1-AMPK is higher than its α2 counterpart and is more sensitive to synergistic allosteric activation by metabolites and small molecules. α2 complexes however show a greater response to energy stress (i.e., AMP production) and appear to be better substrates for LKB1 and mTORC1 upstream. These differences may explain to some extent why in certain cancers α1 is a tumour promoter and α2 a suppressor. β1-AMPK activity is toggled by a 'myristoyl-switch' mechanism that likely precedes a series of signalling events culminating in phosphorylation by ULK1 and sensitisation to small molecules or endogenous ligands like fatty acids. β2-AMPK, not entirely beholden to this myristoyl-switch, has a greater propensity to infiltrate the nucleus, which we suspect contributes to its oncogenicity in some cancers. Last, the unique N-terminal extensions of the γ2 and γ3 isoforms are major regulatory domains of AMPK. mTORC1 may directly phosphorylate this region in γ2, although whether this is inhibitory, especially in disease states, is unclear. Conversely, γ3 complexes might be preferentially targeted by mTORC1 in response to physical exercise.

Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator

Structural Determinants For Small-Molecule Activation Of Skeletal Muscle Ampk Alpha 2 Beta 2 Gamma 1 By The Glucose Importagog Sc4

Study of Amp-Activated Protein Kinase Agonists by Structure-Based Drug Designing

Structural and Biochemical Insights into the Allosteric Activation Mechanism of AMP‐activated Protein Kinase

Modeling Structure–Activity Relationship of AMPK Activation

The metabolic sensor AMPK: Twelve enzymes in one

AMP-activated protein kinase: the current landscape for drug development

Promise and challenges for direct small molecule AMPK activators

AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance

New insights into activation and function of the AMPK

Drug Design for AMP-Activated Protein Kinase Agonists in Silico

Conserved Regulatory Elements in AMPK

Computational screening and QSAR analysis for design of AMP-activated protein kinase agonist

Novel Small-Molecule AMP-Activated Protein Kinase Allosteric Activator with Beneficial Effects in Db/db Mice

Structure of an AMPK complex in an inactive, ATP-bound state

In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes.

Structural insights into the architecture and allostery of full-length AMP-activated protein kinase.

The Energy Sensor AMPK: Adaptations to Exercise, Nutritional and Hormonal Signals

Computer-aided drug design for AMP-activated protein kinase activators.

Deubiquitination and Activation of AMPK by USP10.

Novel Small-Molecule Ampk Activator Orally Exerts Beneficial Effects on Diabetic Db/Db Mice